Two Sigma Investments’s bluebird bio BLUE Stock Holding History

Two Sigma Investments’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,621	Closed	-$2.88M	–	3097
2017 Q3	$2.88M	Buy	+1,621	New	+$2.26M	0.01%	1110
2017 Q2	–	Sell	-1,814	Closed	-$2.14M	–	2960
2017 Q1	$2.14M	Buy	+1,814	New	+$1.85M	0.01%	1414

Other funds holding BLUE

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Two Sigma Investments's BLUE Position: Q2 2025 in Review

Two Sigma Investments sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 13,745 shares — an estimated $67.1K sold.

Two Sigma Investments first reported a position in BLUE in Q2 2014 and held it in 22 quarters. The position peaked at $32.6M in Q2 2015. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Two Sigma Investments reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Two Sigma Investments sold 13,745 bluebird bio shares in Q2 2025, an estimated $67.1K.
Two Sigma Investments first reported a position in bluebird bio in Q2 2014 and held it in 22 quarters.
Two Sigma Investments's bluebird bio position peaked at $32.6M in Q2 2015.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.